| P/E (FY) | — | Sales (TTM) | $4.89B |
| Earnings (TTM) | -$242.0M | ROE | −3.67% |
| Net Margin | −4.92% | ROIC | — |
| Debt / Equity | 0.57 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 2.25% |
Elanco Animal Health innovates, develops, manufactures, and markets products for pets and farm animals worldwide. Its pet health portfolio includes parasiticides, vaccines, and therapeutics under brands such as Seresto, Advantix, Advocate, Credelio, Interceptor Plus, Drontal, and Galliprant, covering flea and tick prevention, pain, otitis, cardiovascular, dermatology, and osteoarthritis. The company also supplies farm animal products.
| Market Cap | $13.18B | Trading Days | 1970 |
| 52W High | 27.72 |
| 52W Low | 13.39 |
| % Off High | −4.80% |
| YTD | 16.62% | 1Y | 83.39% |
| 3Y | 118.64% | 5Y | −27.92% |
| Since incept. (ann.) | −3.88% |
Reportable 100%
| Ann. Volatility (1Y) | 43.64% | Ann. Volatility (3Y) | 47.68% |
| Sharpe (1Y) | 1.59 | Sharpe (3Y) | 0.79 |
| Max Drawdown (1Y) | −26.23% | Max Drawdown (3Y) | −56.10% |
| Beta (3Y, vs SPY) | 2.17 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | $12.61B | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $12.14B | — |
| QNRX | Quoin Pharmaceuticals, Ltd. | $14.34B | — |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.86B | 34.1 |
| AXSM | Axsome Therapeutics, Inc. | $11.70B | — |
| JAZZ | Jazz Pharmaceuticals plc | $16.06B | — |
| BBIO | BridgeBio Pharma, Inc. | $16.36B | — |
| GPCR | Structure Therapeutics Inc. | $10.21B | — |
| SMMT | Summit Therapeutics Inc. | $10.21B | — |
| CORT | CORCEPT THERAPEUTICS INC | $10.05B | 113.4 |
| CYTK | CYTOKINETICS INC |
| $9.75B |
| — |
| IONS | IONIS PHARMACEUTICALS INC | $9.19B | — |